Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
Luciana de Fatima Porini CustodioSuelen Bianca Stopa MartinsLaila Almeida VianaMarina Pontello CristelliLucio Roberto Requião MouraCharles Yea Zen ChowSuzana Friedlander Del Nero CamargoMonica Rika NakamuraRenato Demarchi ForestoHélio Tedesco Silva-JuniorJosé Osmar Medina de Abreu PestanaPublished in: Pediatric transplantation (2024)
These data suggest that induction therapy with a single 3 mg/kg dose of r-ATG is associated with higher efficacy for preventing acute rejection and similar safety profile compared to BAS.